XML 55 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
 3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Segment Reporting, Revenue Reconciling Item [Line Items]    
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
The following table presents revenue by geographic area:
 
Three Months Ended September 30,
(in millions)
2018
United States
$
38,046

International
972

  Total segment revenue
39,018

Corporate (1)
(4
)
Total revenue
$
35,213

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
  
Revenue from External Customers by Geographic Areas [Table Text Block]  
The following table presents revenue by geographic area:
 
Three Months Ended September 30,
(in millions)
2018
United States
$
38,046

International
972

  Total segment revenue
39,018

Corporate (1)
(4
)
Total revenue
$
35,213

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and Corporate:
 
Three Months Ended September 30,
(in millions)
2018
 
2017
Pharmaceutical
$
31,416

 
$
28,920

Medical
3,801

 
3,724

Total segment revenue
39,018

 
32,644

Corporate (1)
(4
)
 
(3
)
Total revenue
$
35,213

 
$
32,641

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The following table presents disaggregated revenue within our two reportable segments:
 
Three Months Ended September 30,
(in millions)
2018
Pharmaceutical distribution and specialty
$
31,209

Nuclear Precision Health Services (1)
207

Pharmaceutical segment revenue
31,416

Medical distribution and products (2)
3,380

Cardinal Health At Home
421

Medical segment revenue
3,801

  Total segment revenue
39,018

Corporate (3)
(4
)
Total revenue
$
35,213

(1)
Our Nuclear Precision Health Services division was formerly referred to as our Nuclear Pharmacy Services division.
(2)
Comprised of all Medical segment businesses except for Cardinal Health At Home division.
(3)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
  
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
 
Three Months Ended September 30,
(in millions)
2018
 
2017
Pharmaceutical
$
409

 
$
467

Medical
135

 
129

Total segment profit
544

 
596

Corporate
272

 
(334
)
Total operating earnings
$
816

 
$
262

  
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
September 30,
2018
 
June 30,
2018
Pharmaceutical
$
21,733

 
$
21,421

Medical
15,670

 
16,066

Corporate
2,608

 
2,464

Total assets
$
40,011

 
$
39,951